Avotres Inc.
Hanover, NJ · Founded 2016 · CIK 0001841331 · Biotech · Private
Therapeutic candidates for immunologically mediated disorders
avotres.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $8.0M
- 2 Form D · May 2023
- 41 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 4 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $4,000,000 | |
| Private capital raised | Form D · SEC | $4,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1859 | Apollomics Inc. | — | $10M |
| 1860 | Syenex, Inc. | — | $8.9M |
| 1861 | SMSbiotech, Inc. | — | $16M |
| 1862 | Avotres Inc. | — | $8.0M |
| 1863 | Bit Global Digital Asset Management Co., Ltd. | — | — |
| 1864 | 3D Bio Holdings, Inc. | — | $7.8M |
| 1865 | Tetragenetics, Inc. | — | $7.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Jihong ChenDirector
- Bruce CooperDirector
- Biao HeDirector
- John HoughtonExecutive Officer
- Hong JiangDirector · Executive Officer
- Yan LeiDirector
- Alex LiDirector
- Xi QinDirector · Executive Officer
- Zhongping SunDirector
- Dan ZhaoDirector
- Zihao ZouDirector
Patents
- Preparation Of A Therapeutic Composition For Treating Autoimmune Diseasesgranted
- A Method For Treating Multiple Sclerosis With Peptide-loaded Dendritic Cellsgranted
- Method For Treating Type I Diabetes With Peptide-loaded Dendritic Cellsgranted
- Detection Of A Defect On Hla-e Restricted CD8+ T Regulatory Cellsgranted
- Preparation Of A Therapeutic Composition For Treating Autoimmune Diseasesapplication
- Therapeutic Preparation And Methods For Treating Autoimmune Diseasesapplication
- A Therapeutic Preparation And Methods For Treating Autoimmune Diseasesapplication
- Therapeutic Preparation And Methods For Treating Autoimmune Diseasesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.